Huons Global Co., Ltd. (084110.KQ)
KRW 46750.0
(-0.53%)
KRW 46750.0
(-0.53%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1317.96 Billion KRW | 6.02% |
| 2022 | 1243.1 Billion KRW | -3.17% |
| 2021 | 1283.74 Billion KRW | 35.27% |
| 2020 | 949.02 Billion KRW | 27.87% |
| 2019 | 742.15 Billion KRW | 10.3% |
| 2018 | 672.87 Billion KRW | 10.28% |
| 2017 | 610.14 Billion KRW | 9.53% |
| 2016 | 557.06 Billion KRW | 77.33% |
| 2015 | 314.13 Billion KRW | 23.42% |
| 2014 | 254.51 Billion KRW | 23.42% |
| 2013 | 206.22 Billion KRW | 11.16% |
| 2012 | 185.51 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1355.73 Billion KRW | 2.19% |
| 2024 Q1 | 1326.64 Billion KRW | 0.66% |
| 2023 FY | 1317.96 Billion KRW | 6.02% |
| 2023 Q3 | 1272.49 Billion KRW | 2.38% |
| 2023 Q2 | 1242.94 Billion KRW | 1.62% |
| 2023 Q1 | 1223.15 Billion KRW | -1.61% |
| 2023 Q4 | 1317.96 Billion KRW | 3.57% |
| 2022 Q4 | 1243.1 Billion KRW | -4.16% |
| 2022 Q1 | 1297.49 Billion KRW | 1.07% |
| 2022 Q2 | 1297.49 Billion KRW | 0.0% |
| 2022 Q3 | 1297.05 Billion KRW | -0.03% |
| 2022 FY | 1243.1 Billion KRW | -3.17% |
| 2021 Q1 | 979.22 Billion KRW | 3.18% |
| 2021 Q2 | 1060.83 Billion KRW | 8.33% |
| 2021 Q3 | 1225.82 Billion KRW | 15.55% |
| 2021 Q4 | 1283.74 Billion KRW | 4.73% |
| 2021 FY | 1283.74 Billion KRW | 35.27% |
| 2020 FY | 949.02 Billion KRW | 27.87% |
| 2020 Q1 | 755.89 Billion KRW | 1.85% |
| 2020 Q3 | 879.75 Billion KRW | 2.08% |
| 2020 Q4 | 949.02 Billion KRW | 7.87% |
| 2020 Q2 | 861.82 Billion KRW | 14.01% |
| 2019 FY | 742.15 Billion KRW | 10.3% |
| 2019 Q2 | 696.1 Billion KRW | -0.62% |
| 2019 Q4 | 742.15 Billion KRW | 3.56% |
| 2019 Q1 | 700.44 Billion KRW | 4.1% |
| 2019 Q3 | 716.61 Billion KRW | 2.95% |
| 2018 Q2 | 622.53 Billion KRW | 0.24% |
| 2018 Q4 | 672.87 Billion KRW | 5.31% |
| 2018 Q3 | 638.97 Billion KRW | 2.64% |
| 2018 Q1 | 621.02 Billion KRW | 1.78% |
| 2018 FY | 672.87 Billion KRW | 10.28% |
| 2017 Q1 | 565.9 Billion KRW | 1.59% |
| 2017 Q2 | 574.17 Billion KRW | 1.46% |
| 2017 Q3 | 593.3 Billion KRW | 3.33% |
| 2017 FY | 610.14 Billion KRW | 9.53% |
| 2017 Q4 | 610.14 Billion KRW | 2.84% |
| 2016 Q1 | 339.25 Billion KRW | 8.0% |
| 2016 FY | 557.06 Billion KRW | 77.33% |
| 2016 Q4 | 557.06 Billion KRW | 1.31% |
| 2016 Q3 | 549.86 Billion KRW | 164.82% |
| 2016 Q2 | 207.64 Billion KRW | -38.8% |
| 2015 FY | 314.13 Billion KRW | 23.42% |
| 2015 Q4 | 314.13 Billion KRW | 3.32% |
| 2015 Q3 | 304.03 Billion KRW | 10.84% |
| 2015 Q2 | 274.29 Billion KRW | 4.01% |
| 2015 Q1 | 263.7 Billion KRW | 3.61% |
| 2014 Q1 | 213.78 Billion KRW | 3.67% |
| 2014 FY | 254.51 Billion KRW | 23.42% |
| 2014 Q3 | 221.82 Billion KRW | 4.26% |
| 2014 Q4 | 254.51 Billion KRW | 14.74% |
| 2014 Q2 | 212.75 Billion KRW | -0.48% |
| 2013 Q2 | 194.19 Billion KRW | 2.03% |
| 2013 Q1 | 190.33 Billion KRW | 2.6% |
| 2013 Q4 | 206.22 Billion KRW | 1.41% |
| 2013 Q3 | 203.35 Billion KRW | 4.71% |
| 2013 FY | 206.22 Billion KRW | 11.16% |
| 2012 FY | 185.51 Billion KRW | 0.0% |
| 2012 Q4 | 185.51 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | 141.35 Billion KRW | -832.401% |
| CMG Pharmaceutical Co., Ltd. | 186.85 Billion KRW | -605.353% |
| Celltrion Pharm, Inc. | 641.64 Billion KRW | -105.404% |
| DongKook Pharmaceutical Co., Ltd. | 839.53 Billion KRW | -56.987% |
| Enzychem Lifesciences Corporation | 211.54 Billion KRW | -523.017% |
| Humedix Co., Ltd. | 219.97 Billion KRW | -499.135% |
| Boditech Med Inc. | 227.9 Billion KRW | -478.304% |
| EuBiologics Co., Ltd. | 172.64 Billion KRW | -663.41% |
| FutureChem Co.,Ltd | 72.83 Billion KRW | -1709.566% |
| Huons Co., Ltd. | 537.28 Billion KRW | -145.301% |
| BNC Korea Co., Ltd. | 236.15 Billion KRW | -458.099% |
| AptaBio Therapeutics Inc. | 92.51 Billion KRW | -1324.532% |